Last edition
News about "Phase 3 Trials "
Litfulo Shows Significant Repigmentation Benefits in Phase 3
Pfizer’s two phase 3 trials showed significant improvements in facial and total body repigmentation compared with placebo.
Phase 3 Trials | 05/10/2026 | By News Bureau
Roche Reports New Real-World Vabysmo Data Across Retinal Conditions
Roche’s VOYAGER study provides real-world data on Vabysmo’s effectiveness, durability and safety across multiple retinal conditions.
Phase 3 Trials | 03/10/2026 | By News Bureau
First-in-class therapy approved to treat agitation linked to Alzheimer’s disease, addressing a major unmet need for patients and caregivers.
Phase 3 Trials | 04/05/2026 | By News Bureau | 165
Lupin Completes Phase 3 Trials for Lucentis Biosimilar
Lupin has successfully completed a global Phase 3 clinical study of LUBT010, its biosimilar candidate to Lucentis.
Phase 3 Trials | 06/08/2024 | By Aishwarya | 765
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy